Overview
TARA market data
Price History
TARA price chart · 1M
- O
- 3.94
- H
- 4.04
- L
- 3.91
- C
- 4.00
- Vol
- 21,292.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $3.94
- Previous Close
- $3.92
- Day High
- $4.04
- Day Low
- $3.91
- 52 Week High
- $5.69
- 52 Week Low
- $3.62
- 7 Day Return
- +2.30%
- 30 Day Return
- +1.14%
- 90 Day Return
- -14.27%
- 1 Year Return
- -22.88%
- Daily Notional Volume
- $85.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.34 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.46 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -113.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.02 – $7.82 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $233.7M · P/B 1.40.
Company News
Protara Therapeutics Q2 EPS $(0.36) Misses $(0.33) EstimateBenzinga · Aug 11, 2026, 12:07 PM
8-K filing — Protara Therapeutics, Inc. (TARA)SEC EDGAR · Aug 11, 2026, 12:05 PM
Protara Therapeutics Enters $100M At-the-Market Equity Sales Agreement With TD CowenBenzinga · May 28, 2026, 9:20 PM